skip to Main Content

graphic that reads "TAG at 30" the photo is of three young white men behind a table. It's Mark Harrington, Gregg Gonsalves, and Spencer Cox in Amsterdam in 1992
graphic that reads "limited art editions" the image is 18 small "slices" and each of those is a small piece of one of TAG's limited art editions
Image link to About the COVID-19 Project page
Cover of Pipeline Report 2022. Black cover with grey type and decorative bright green lines

Pipeline Reports

The current ones are all online and available for download now.

 

October 6, 2022
Treatment Action Group Statement: U.S. District Court Ruling Allowing Employers to Deny PrEP Coverage Is a Dangerous Attack on Public Health
Statement / Press
Treatment Action Group (TAG)  unequivocally condemns the September 2022 U.S. District Court ruling in Fort Worth, Texas on the case Braidwood Management Inc. et al., v. Xavier Becerra et al., which ruled that the Affordable Care Act’s requirement that employers cover pre-exposure prophylaxis (PrEP) for HIV prevention was unconstitutional.

October 5, 2022
Digital Communications Consultant
Treatment Action Group (TAG) is seeking to engage a creative, highly motivated Digital Communications Consultant.

October 4, 2022
Chief Operating Officer
Treatment Action Group (TAG) is seeking a dynamic, seasoned, and strategic leader to become TAG’s Chief Operating Officer, supporting the organization as it continues to grow.

September 21, 2022
The LAT CAB Responds to MedinCell and Medicines Patent Pool License on a New Long-Acting Malaria Formulation
Statement / Press
As the global Long-Acting Technologies Community Advisory Board (LAT CAB) representing vast civil society networks, and people living with and affected by malaria, HIV, tuberculosis, and the hepatitis C virus (HCV) across the world, we welcome the efforts leading to the development of an investigational long-acting injectable (LAI) formulation of…

September 16, 2022
COVID-19 and Monkeypox: When Will They End?
Webinar / Presentation
With the emergence of MPV and the existing COVID-19 pandemic, there is growing concern amongst communities broadly on what the future holds. On September 29, please join Treatment Action Group, Black AIDS Institute, and the Coronavirus Prevention Network (CoVPN) with special guests Dr. Demetre Daskalakis, Justin James (Twitter: @TheKingOfReads), and…

September 16, 2022
Toward an Actionable and Rigorous United States Monkeypox Research Agenda
Letter / Comment
On September 14, 2022, a coalition of activists, researchers, and public health professionals sent the following letter to the White House MPX Coordinators, OSTP, CDC, and NIH/NIAID asking for a coordinated and adequately funded comprehensive Federal research effort to contain, control, and ultimately eliminate monkeypox in the US and around…

September 15, 2022
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

August 24, 2022
Pathways Forward to End HIV: How HIV Cure Research is Helping to Advance HIV Vaccine Research
Webinar / Presentation
On September 20, please join Treatment Action Group, Dr. Shelly Karuna, and Dr. Karine Dubé for a webinar on the next generation of bnAbs trial design and ethics related to ATIs in HIV vaccine and cure research.

August 23, 2022
Treatment Action Group Statement on Retirement of Dr. Anthony S. Fauci
Statement / Press
Treatment Action Group (TAG) meets with sadness the announcement by Dr. Anthony S. Fauci of his retirement as Director of the National Institute of Allergy and Infectious Diseases (NIAID), Chief of the NIAID Laboratory of Immunoregulation, and Chief Medical Advisor to President Biden, effective in December 2022.

August 23, 2022
Ten Principles for Access to Multi-disease Molecular Diagnostics: A Global Call to Action
Statement / Press
Treatment Action Group (TAG) and Médecins Sans Frontières (MSF) Access Campaign are pleased to launch the Principles for Access to Multi-disease Molecular Diagnostics.

August 23, 2022
Treatment Action Group Adds Three New Board Members
Statement / Press
As it celebrates its 30th Anniversary year, Treatment Action Group (TAG) announced the election of David Puente, Michael Montero and Ivy Kwan Arce to its Board of Directors.

August 18, 2022
Monkeypox Vaccine Equity Letter to NYS and NYC Health Commissioners Dr Bassett and Dr Vasan
Letter / Comment
An open letter from community partners, including TAG, asking for a mixed ID/SQ does strategy for monkeypox vaccination and demanding flexibility from our federal partners.

August 5, 2022
Senior TB Project Associate
Treatment Action Group (TAG) is seeking a dynamic, highly motivated, and organized Senior TB Project Associate to support community engagement activities under the SMART4TB Project – a $200 million investment made by USAID to Support, Mobilize, and Accelerate Research for TB Elimination.

August 1, 2022
New Rifapentine Formulations at New Prices: No Excuses for Not Scaling-Up TB Preventive Treatment
Statement / Press
We, the undersigned civil society and community-based organizations, welcome the announcement by Unitaid and its partners that they have reached an agreement with Lupin Limited and Macleods Pharmaceuticals to introduce two formulations of rifapentine at competitive prices.

August 1, 2022
LAT CAB Calls on AbbVie, Licensed Generic Manufacturers of G/P, and the Medicines Patent Pool to Fulfill their Commitment to Make Generic HCV Treatment Widely Available
Statement / Press
Four years after the Medicines Patent Pool (MPP) and AbbVie came to agreement on a voluntary license authorizing MPP to sublicense G/P to generic manufacturers to ensure commercialization in low- and middle-income countries, generic G/P is not available anywhere.

July 31, 2022
1 / 4 / 6 x 24 Campaign Launched to Rally Energy, Political Will, Funding Needed to Fight Tuberculosis
Statement / Press
Against the backdrop of the COVID-19 pandemic and other concurrent global health, economic, social, and political crises, the 1 / 4 / 6 x 24 Campaign, launched during the AIDS conference in Montreal, seeks to improve TB treatment and prevention worldwide based on the latest medical innovations and to reignite…

July 28, 2022
LAT CAB Video Presentation
Webinar / Presentation
This video, offered here in English, French, and Spanish, was made to be shown at the AfroCAB booth at the 24th International AIDS Conference.

July 25, 2022
1 / 4 / 6 x 2024
Webinar / Presentation
Inspired by the legacy of Dr. Paul Farmer, the 1 / 4 / 6 x 24 Campaign calls for the “staff, stuff, space, systems and support” necessary to make groundbreaking short-course TB prevention and treatment regimens accessible to all who need them as a human right by the end of 2024.

July 24, 2022
2022 Pipeline Report
Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

July 18, 2022
TB CAB 10-Year Anniversary Evaluation Report 2011–2021 and Podcast
Publication
In 2021, the Global Tuberculosis Community Advisory Board (TB CAB) celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.

July 8, 2022
Research in Action Awards 2022
Save the date for Tuesday, November 16, 2021! TAG’s 2021 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world. This year we’ll once again gather virtually…

July 1, 2022
Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline
Statement / Press
A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global Fund’s Expert Review Panel (ERP), an independent group of experts that reviews finished pharmaceutical products and makes recommendations on their use to the Global Fund.

June 23, 2022
Roundtable on Access to Multi-disease Molecular Diagnostics
Webinar / Presentation
On June 2, 2022, Treatment Action Group (TAG) and Médecins Sans Frontières (MSF) hosted a Roundtable on Access to Multi-disease Molecular Diagnostics, which brought together country program representatives, donors, members of civil society, and other global health actors to: Identify ways to leverage the availability of new multi-disease molecular diagnostic…

June 23, 2022
Treatment Action Group Statement on NYC DOHMH Monkeypox Vaccination Announcement
Statement / Press
In response to this morning’s announcement by the New York City Department of Health and Mental Hygiene (NYC DOHMH) that the DOHMH would open a temporary monkeypox vaccination clinic at the Chelsea Sexual Health Clinic in New York, Treatment Action Group’s Executive Director, Mark Harrington, and TAG HIV Project Director…

June 17, 2022
Letter to WTO Condemning Failure to Waive IP Rules
Letter / Comment
TAG and 300 NGOs worldwide condemn the U.S., U.K., E.U., & Switzerland for blocking an intellectual property waiver for purposes of global COVID-19 vaccine production. In light of this shameful failure, we urge countries to act outside of WHO structures to save lives.

Back To Top